Accuracy of Papanicolaou test among HIV-infected women

Clinical Infectious Diseases

Volumn 42, Issue 4, 2006, Pages 562-568

  Anderson, Jean R ^a,e   Paramsothy, Pangaja ^c   Heilig, Charles ^d   Jamieson, Denise J ^d   Shah, Keerti ^b   Duerr, Ann ^d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOPSY; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COLPOSCOPY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIRAL LOAD;

EID: 32044454688     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/499357     Document Type: Article

References (14)

1. Maiman M. Management of cervical neoplasia in human immunodeficiency virus-infected women. Monogr Natl Cancer Inst 1998;23: 43-9.
2. Six C, Heard I, Bergeron C, et al. Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS 1998;12: 1047-56.
3. Hoyo C, Miller WC, Newman BM, Fortney JA. Selective screening for cervical neoplasia: an approach for resource-poor settings. Int J Epidemiol 2000;29:807-12.
4. Maiman M, Tarricone N, Vieira J, Suarez J, Serur E, Boyce JG. Colposcopic evaluation of human immunodeficiency virus seropositive women. Obstet Gynecol 1991;78:84-8.
5. Fruchter RG, Maiman M, Sillman FH, Camilien L, Webber CA, Kim DS. Characteristics of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus. Am J Obstet Gynecol 1994;171:531-7.
6. Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol 1994;84:591-7.
7. Korn AP, Autry M, DeRemer PA, Tan W. Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:401-4.
8. Adachi A, Fleming I, Burk RD, Ho GY, Klein RS. Women with human immunodeficiency virus and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome. Obstet Gynecol 1993;81:372-7.
9. Spinillo A, Capuzzo E, Tenti P, De Santolo A, Piazzi G, Iasci A. Adequacy of screening cervical cytology among human immunodeficiency virus seropositive women. Gynecol Oncol 1998;69:109-13.
10. Smith DK, Warren DL, Vlahov D, et al. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997;146: 459-69.
11. Fink MJ, Fruchter RG, Maiman M, et al. The adequacy of cytology and colposcopy in diagnosing cervical neoplasia in HIV-seropositive women. Gynecol Oncol 1994;55:133-7.
12. Boardman LA, Peipert JF, Cooper AS, Cu-Uvin S, Flanigan T, Raphael SI. Cytologic-histologic discrepancy in human immunodeficiency virus-positive women referred to a colposcopy clinic. Obstet Gynecol 1994;84:1016-20.
13. Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA 1989;26I:737-43.
14. Goodman A, Chaudhuri PM, Tobin-Enos NJ, Hutchinson ML. The false-negative rate of cervical smears in high risk HIV seropositive and seronegative women. Int J Gynecol Cancer 2000;10:27-32.